Nutex Health Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio3.31
P/S Ratio0.360.495.64
P/B Ratio0.911.5310.28
Price/Tangible Book1.675.0621.46
Price/FCF8.2634.39
Price/OCF7.4496.1024.45
Enterprise Value Ratios
EV/Revenue0.931.766.77
EV/EBITDA2.8626.79173.52
EV/EBIT3.25
EV/FCF21.4841.25
Profitability & Returns
Return on Equity (ROE)0.71%-0.44%-2.77%0.99%1.47%
Return on Assets (ROA)0.16%0.00%-0.01%0.31%0.39%
Return on Invested Capital (ROIC)0.29%0.00%-0.01%0.57%0.70%
Return on Capital Employed (ROCE)0.28%0.00%-0.01%0.49%0.55%
Leverage & Solvency Ratios
Debt/Equity1.803.492.220.931.02
Debt/EBITDA2.1414.5523.190.970.94
Debt/FCF16.327.431.315.89
Liquidity Ratios
Current Ratio1.901.561.794.094.31
Quick Ratio1.791.451.694.004.25
Efficiency Ratios
Asset Turnover0.910.600.530.941.12
Inventory Turnover84.8456.4160.1063.7079.65
Yield & Distribution Ratios
Earnings Yield0.30%-0.38%-0.34%
FCF Yield0.12%-0.07%0.03%
Payout Ratio0.84%0.43%
Buyback Yield-0.25%-0.04%-0.07%